Erzofri 39 MG per 0.25 ML Extended Release Injectable Suspension in a Prefilled Syringe

RxCUI: 2699353
RxNorm name: Erzofri 39 MG per 0.25 ML Extended Release Injectable Suspension in a Prefilled Syringe
Display name: Erzofri 39 MG per 0.25 ML Extended Release Injectable Suspension in a Prefilled Syringe
Full name: Erzofri 39 MG per 0.25 ML Extended Release Injectable Suspension in a Prefilled Syringe
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:38:56

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Erzofri extended-release	PALIPERIDONE PALMITATE	Shandong Luye Pharmaceutical Co., Ltd.	492bf9dd-868e-421a-92db-8cca8973aac1	2026-03-09	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2699353

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
492bf9dd-868e-421a-92db-8cca8973aac1	Erzofri 39 MG per 0.25 ML Extended Release Injectable Suspension in a Prefilled Syringe	SY	7	These highlights do not include all the information needed to use ERZOFRI ® safely and effectively. See full prescribing information for ERZOFRI ® . ERZOFRI ® (paliperidone palmitate) extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 2006	20260309
492bf9dd-868e-421a-92db-8cca8973aac1	Erzofri 39 MG in 0.25 ML Prefilled Syringe	PSN	7	These highlights do not include all the information needed to use ERZOFRI ® safely and effectively. See full prescribing information for ERZOFRI ® . ERZOFRI ® (paliperidone palmitate) extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 2006	20260309
492bf9dd-868e-421a-92db-8cca8973aac1	0.25 ML paliperidone palmitate 156 MG/ML Prefilled Syringe [Erzofri]	SBD	7	These highlights do not include all the information needed to use ERZOFRI ® safely and effectively. See full prescribing information for ERZOFRI ® . ERZOFRI ® (paliperidone palmitate) extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 2006	20260309
492bf9dd-868e-421a-92db-8cca8973aac1	Erzofri 39 MG per 0.25 ML Prefilled Syringe	SY	7	These highlights do not include all the information needed to use ERZOFRI ® safely and effectively. See full prescribing information for ERZOFRI ® . ERZOFRI ® (paliperidone palmitate) extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 2006	20260309